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The salts, Na[ROC(O)Ph], Na[1-ROC(O)-1,12-C2B10H11], K2[1,4-(ROC(O))2-C6H4] and 
K2[1,12-(ROC(O))2-1,12-C2B10H10] where R is the cobaltabis(dicarbollide)-diethylene 
glycol group [3,3’-Co(8-(OCH2CH2OCH2CH2)-1,2-C2B9H10)(1’,2’-C2B9H11)]
-, were 
synthesized from the corresponding carboxylate salt and the zwitterion [3,3’-Co(8-
(CH2CH2O)2-1,2-C2B9H10)(1’,2’-C2B9H11)]. The dianion in K2[1,12-(ROC(O))2-1,12-
C2B10H10] showed at least one K
+ cation to be tightly bound to the dianion via K···O and 
K···H-B interactions with both para-carborane and cobaltabis(dicarbollide) clusters 
based on NMR and MS data and supported by hybrid-DFT computations. Evaluation of 
the antimicrobial properties of these compounds revealed all salts to be highly effective 
antibacterial agents for four Gram-positive bacteria strains (standard minimum inhibitory 
concentration, MIC, of 1 mg/L for Na[ROC(O)Ph]; Na[3]) and antifungal agents for three 
Candida albicans strains (MIC 4 mg/L for the salts K2[4] and K2[6]). One of the four 
Gram-positive bacteria strains tested was a life-threatening superbug methicillin-resistant 
Staphylococcus aureus (MRSA) isolate, which is resistant to many commercial 
antimicrobial drugs. The cobaltabis(dicarbollide) derivative, Na[3], has a remarkable 
inhibitory effect on the MRSA strain with a MIC of only 1 mg/L and a minimum 
bactericidal concentration (MBC) of 2 mg/L thus suggesting its potential as an 









Most of the FDA approved anticancer and antibacterial drugs are purely organic 
molecules, which can incorporate nitrogen, oxygen, and halogens - all of them right-hand 
neighbors of carbon. The determination of vitamin B12 (cyano-cobalamin) structure1 as well 
as the successful introduction of cisplatin as an anticancer drug2 in the early 1980s opened 
the door to potential applications of organometallic complexes in medicine.3 
Boron is located on the left side of the carbon in the Periodic Table. Boron and 
carbon are elements that have the property to build molecules of unlimited size by 
covalent self-bonding. The twelve-vertex C2B10H12 carboranes, ortho-, meta-, or para- 
isomers (Chart 1), rank among the most chemical and biological stable molecular 
compounds known.4,5 Metallacarboranes are derivatives of carboranes with metal atoms 
in the cluster framework.4 The metallabisdicarbollide [3,3’-Co(1,2-C2B9H11)2]
- [1]- (Chart 
1), in which the metal ion is sandwiched between two [C2B9H11]
2- ligands, is the most 
studied icosahedral metallacarborane.6 The anion, [1]-, is thermally and chemically stable, 
its negative charge is spread all over the molecule,4,7 possesses hydrogen and dihydrogen 
bonds (Cc-H···O and Cc-H···H-B, respectively; Cc = cluster carbon atom) capabilities 
which have been present in self-assemblies,8 water solubility,9 micelle and vesicle 






Chart 1. Representation and numbering of icosahedral carboranes (ortho-, meta-, or 
para- isomers) and the organometallic compounds, anion [1]- and zwitterion 2. 
 
The metallacarborane [1]- anion is a highly compact Greek letter θ shaped 
molecule ready for stepwise substitutions at boron atoms.6 The derivatization of the 
cobaltabis(dicarbollide) through the easy synthesis of the zwitterion 8-dioxanate [3,3’-
Co(8-(CH2CH2O)2-1,2-C2B9H10)(1’,2’-C2B9H11)], 2 in Chart 1, in a high yield11
,12  opened 
the way for new applications of this organometallic anion. The mononuclear complex 2  
is susceptible to nucleophilic attack on the positively charged oxygen atom, e.g. by 
pyrrolides,13 imide, cyanide or amines,14 phenolate, dialkyl or diarylphosphite,15 N-
alkylcarbamoyldiphenylphosphine oxides,16 alkoxides,12,17 nucleosides,18 and carboranyl 
anions19 yielding many anionic diethylene glycol cobaltabisdicarbollide species formed 
by the opening of the dioxane ring. 
 Boron compounds (e.g. boronic acids, boron heterocycles, carboranes) in 
medicine are usually associated with the properties of boron as element within deltahedral 
species primarily to exploit the 10B isotope for neutron capture which led to the 
development of the Boron Neutron Capture Therapy (BNCT) as anticancer agents.20 
Some boron compounds can also show promise as effective antibacterial and antifungal 
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agents.21,22 In 2013, some of us screened derivatives of [1]- to evaluate their putative 
antimicrobial properties against 16 pathogenic Gram-positive and Gram-negative 
bacterial strains and 3 strains of fungal Candida spp. where salts A and B in Chart 2 were 
the most effective antimicrobial agents against all strains.23 A derivative of [1]-, [3,3’-
Co(8-CH3CH2O-1,2-C2B9H10)(8’-I-1’,2’-C2B9H10)]
-, C, was reported by Wang and co-
workers to possess a high bacteria-killing efficiency with eradication of all TSA MRSA 
cells within 30 min.24 However, this compound was not effective for other Gram-positive 
and Gram-negative bacteria tested. Recently, Šícha and co-workers reported that the salt 
Na[1] and zwitterions such as D, E and F were effective against Gram-positive bacteria 
and filamentous fungi but not Gram-negative bacteria and Candida spp. (yeast fungi).25,26 
 
Chart 2. Known cobaltabis(dicarbollide) derivatives with effective antimicrobial 
properties. Compounds A-C are anionic and D-F are zwitterion. 
Medical treatment for some microbial illnesses is complicated nowadays by the 
appearance of new multi-resistant strains, and therefore, a new class of highly selective 
antimicrobial boron‐ containing compounds could be of importance.27 Following our 
studies on metallacarboranes’ direct substitution, we report herein high yield syntheses 
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of polyanionic species incorporating the cobaltabis(dicarbollide) anion as novel high-
boron content molecules with enhanced water solubility. Two of these new assemblies 
include the para-carborane cluster and the others the para-phenyl group. These 
assemblies were tested here with 4 Gram-positive bacteria, 5 Gram-negative bacteria and 
3 Candida albicans strains that were previously responsible for human infections, and all 
were found to be effective against Gram-positive bacteria and fungi. 
 
Results and discussion 
Synthesis and characterization 
The synthetic strategy for the preparation of the Co(III) compounds, Na[3], K2[4], 
Na[5] and K2[6], is outlined in Scheme 1. These salts were obtained by the ring-opening 
reaction of cyclic oxonium [3,3’-Co(8-(CH2CH2O)2-1,2-C2B9H10)(1’,2’-C2B9H11)] 
zwitterion 2,11,12 with organic ([C6H5COO]
- and [C6H4-1,4-(COO)2]
2-) and inorganic 
carboxylates ([1-COO-1,12-C2B10H11]
- and [1,12-(COO)2-1,12-C2B10H10]
2-), as  
nucleophiles. Sodium salts of the monoacid ligands, benzoic and 1-COOH-1,12-C2B10H11 
acids, provided nucleophiles on 2 to produce the monoanionic Na[3,3’-Co(8-
O(CH2CH2O)2C(O)C6H5-1,2-C2B9H10)(1’,2’-C2B9H11)], Na[3], and Na[3,3’-Co(8-
O(CH2CH2O)2C(O)-1,2-C2B9H10)(1’,2’-C2B9H11)-1,12-C2B10H11], Na[5], respectively. 
The potassium salt, generated in situ from terephthalic acid and potassium carbonate, 
contained the nucleophile used to attack 2 to afford the di-anionic compound K2[1’’,4’’-
{3,3’-Co(8-O(CH2CH2O)2CO-1,2-C2B9H10)(1’,2’-C2B9H11)}2-C6H4] K2[4]. Likewise 
K2[1’’,12’’-{3,3’-Co(8-O(CH2CH2O)2CO-1,2-C2B9H10)(1’,2’-C2B9H11)}2-1’’,12’’-
C2B10H10] K2[6], was formed from the salt generated from K2CO3 and 1,12-C2B10H10-
1,12-(COOH)2 with the zwitterion 2. After stirring overnight at ambient temperatures, the 
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anionic compounds were isolated as orange solids by evaporation of the solvent. Complex 
K2[4] was further separated and purified through column chromatography in silica.  
 
 
Scheme 1. Synthetic routes used in this work. 
 
The isolated compounds were characterized by FT-IR, NMR (1H, 11B, 13C{1H} 
nuclei) spectroscopies, and mass spectrometry. IR spectra of these new salts show 
vibrations around 2960-2860 cm-1 assigned to C-H stretching modes for the chain of the 
dioxane opened ring while the Cc-H stretches of the 1,12-C2B10H11 unit in Na[5] and 
cobaltabis(dicarbollide) units appear at 3048 cm-1. Significant bands around 2530 cm-1  
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correspond to the B-H stretching modes for the B-H bonds of the boron cluster units. 
Strong bands are also observed at 1700 cm-1 and assigned to ѵC=O stretching band of the 
carboxyl group present in the compounds. 
One-dimensional (1D) NMR spectra of all new salts were recorded in d6-acetone 
(see S.I.) and are consistent with the structures displayed in Scheme 1. Proton NMR peaks 
of B(8)-OCH2-, -CH2OCH2- and -CH2-R in all salts were observed in the range between 
4.47 and 3.52 ppm. The presence of Cc-H signals corresponding to the 
cobaltabis(dicarbollide) unit appear as a broad signal around 4.25 ppm. The salts, Na[3] 
and K2[4], exhibit signals in the aromatic region associated with the presence of aromatic 
phenyl rings. In the case of compound Na[5], the resonance corresponding to Cc-H of the 
1,12-C2B10H11 moiety appears at 3.32 ppm. 
The 11B{1H} NMR spectra of the four anions in the new salts featured an identical 
1:1:1:1:2:2:4:2:2:1:1 pattern ranging from +25 to -30 ppm corresponding to the 
metallacarborane unit with values listed in Table 1. The resonance at the lowest field 
remains as a singlet in the 11B NMR spectrum and corresponds to the B(8) substituted 
boron atom. As shown in Figure 1, anion [5]- could be considered as the sum of the 
fragment I and fragment II. The schematic representation of the 11B{1H} NMR spectrum 
of the [5]- consists of 13 peaks with a 1:1:1:1:2:2:4:5:5:2:2:1:1 intensity ratio; 11 
resonances from the fragment I (1:1:1:1:2:2:4:2:2:1:1) plus 2 resonances (5:5) from the 




















                         
Figure 2. a) Schematic representation of 11B{1H} NMR spectrum of anion [5]- as the sum of the fragment 
I and II and b) experimental 11B{1H} NMR spectrum of Na[5]. 
  





Table 1. 11B{1H} NMR chemical shifts (ppm) of the cobaltabis(dicarbollide) unit in compounds [3]--[6]2-. 
B(8) values correspond to B-O resonances. 
 B(8) B(8′) B(10) B(10′) B(4′,7′) B(4,7) B(9,9’, 
12,12’) 
B(5′,11′) B(5,11) B(6) B(6′) 
[3] - 23.0 4.0 0.5 -2.4 -4.1 -7.4 -8.3 -17.2 -20.3 -21.9 -28.5 
[4] 2- 24.1 5.1 1.3 -1.6 -3.5 -6.5 -7.4 -16.5 -19.6 -20.9 -28.3 
[5] - 22.6 3.7 0.1 -2.8 -4.6 -7.8 -8.6 -17.7 -20.8 -22.3 -29.0 
[6]2- 24.2 5.1 1.5 -1.4 -3.2 -6.3 -7.2 -16.2 -19.4 -21.0 -27.6 
 
The boron-decoupled proton 1H{11B} NMR spectra reveal broad BH peaks characteristic 
of the 8-substituted cobaltabis(dicarbollide) anion in all complexes. These peaks are 
usually in a 4:2:1:1:2:2:2:2:1 peak integral ratio and, in deuterated acetone, the shifts are 
in the 3.0-2.7 ppm region for 4:2:1 and in the 2.0 to 1.4 ppm range for 2:2:2:2:1. There is 
a peak of intensity 1 in the 2.4 ppm region for a 8-substituted cobaltabis(dicarbollide) 
anion which is in the same region expected for the B-H shift corresponding to the protons 
of the substituted para-carborane at the B2-B6 vertices. Figure 3 shows the 2.6 to 1.9 
ppm region for the para-carborane precursors and the para-carborane salts, Na[5] and 
K2[6]. There are two B-H peaks at 2.43 and 2.22 ppm with intensity ratio of 6:5 in Na[5] 
which is in accord with the two distinct set of BH peaks with 5:5 ratio plus a BH peak 
from the cobalt cluster anion. However, instead of the expected peak intensity ratio of 
2:10 for K2[6] with two BH protons from the cobaltabis(dicarbollide) and all 10 
equivalent BH protons from the para-carborane cluster, there are three peaks at 2.49, 2.44 
and 2.40 ppm with a 4:4:4 integral ratio. Peak fitting analysis suggests that the para 
carborane B-Hs are 4:2:4 with a broader peak of two B-Hs from the cobalt cluster at 2.44 
ppm (Figure S33).  These peaks indicate that not all protons at the para-carborane unit 
are equivalent in K2[6] and there is likely to be at least one potassium cation in close 
interaction with the neutral closo-carboranyl unit in solution resulting in non-equivalent 




Figure 3. 1H{11B} NMR spectra of (a) Na[1-COO-1,12-C2B10H11], (b) Na2[1,12-(COO)2-1,12-C2B10H10], 
(c) Na[5] and (d) K2[6] in (CD3)2CO (CD3COCHD2 at 2.06 ppm and, if present, CH3COCH3 is at 2.09 
ppm). 
 
 For monoanions [3]- and [5]-, the ESI-MS spectra displayed peaks at m/z 532.2 
and 598.4, respectively, that correspond in both cases to the molecular weight of the 
monoanionic species. In the case of K2[4], the most intense peak corresponding to M/2 
appears at m/z 493.2 with a separation between isotopic peaks distribution of 0.50 m/z 
units that unambiguously identifies the species as the di-anion fragment, with M as the 
molecular weight of the dianionic [4]2- species. In addition, three peaks with a separation 
between isotopic peaks distribution of 1 m/z units at m/z 620.2, 428.2, and 383.2 










Figure 4. Fragmentation of the dianions [4]2- and [6]2- species into their monoanion fragments. 
 
The ESI-MS spectrum of K2[6] displays three major peaks (Figure 5). The peak 
at 525.8 with a separation between isotopic peaks distribution of 0.50 m/z units 
corresponds to M/2 with M as the molecular weight of the dianion [6]2-. The peak at 642.3 
matches to the monoanionic fragment [8-(HOOC-C2B10H10-COO-(CH2CH2O)2-3,3’-
Co(1,2-C2B9H10)(1,2-C2B9H11)]
-, while the third peak at 1091.7 agrees with the 
monoanion consisting of K+ and [6]2-. The peak at 1091.7 assigned as [(M + K)]- would 
be due to the strong O···K···O interactions between the cation K+ and the polyether chains 
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in the dianion and K···H-B interactions between the cation and the hydrogen atoms of the 
B-H of the carborane. This behavior was observed in a similar anionic diethylene glycol 
cobaltabis(dicarbollide) species containing K+ as cation.13 The peak of [(M+K)]- was not 
present in the dinuclear compound K2[4] which suggests structural differences exist 
between the two K2[4] and K2[6] salts due to the presence of the 2D phenylene and 3D 
carboranylene linkers respectively. Intramolecular interactions between K+ and the 
accessible B-H vertices of the carboranyl group, which are hydridic, may be responsible 
for the observed mass spectra differences between the linkers in K2[4] and K2[6]. 
 
 
Figure 5. ESI-MS spectra of K2[6]. 
 
Thermogravimetric profiles were recorded for the new salts Na[3], K2[4], Na[5] 
and K2[6]. The compound Na[3] gave only one weight loss of 23.3 % at around 200 ˚C 
corresponding to the removal of the C2H4OCO-1,4-C6H5 group. Salt Na[5] revealed three 
distinct weight losses with a total elimination of 32.32 % in the temperature range 150 – 
550 ºC in accord with the breaking of the C2H4OCO-1,12-C2B10H11 branch. The dianionic 




– 470 ºC  and points to the elimination of the (C2H4OC2H4OCO)2-1,4-C6H4 fragment. 
However, the TGA of the dianionic K2[6] complex displays only one weight loss of 35.5 
% at around 150 ºC which may correspond to the removal of the central 
(C2H4OC2H4OCO)2-1,12-C2B10H10 part of the [6]
2- dianion.  
Geometry optimizations by hybrid-DFT computations on the anions of Na[3], 
K2[4], Na[5] and K2[6] within the salts revealed the expected geometries of the discrete 
anions [3]-, [4]2-, [5]- and [6]2- (Figures S38-S41). As the salt K2[6] revealed a K[6]
- peak 
in the ESI MS and clear K+ interactions with the B-H hydrogens of the para-carborane 
unit in solution in the 1H{11B} NMR spectrum, the K[6]- geometries were looked at 
computationally. In the most stable minimum of K[6]- located, there are two close K+…O 
interactions, three K+…H-B interactions with the cobaltabis(dicarbollide) cluster and two 
K+…H-B interactions with the para-carborane cluster (Figure 6). The strong K+ binding 
with the dianion [6]2- observed experimentally is supported by hybrid-DFT computations. 
The environment at K+ in {K[6]}- is remarkably similar to the X-ray crystal structure of 
the potassium salt of the pyrrolyl cobaltabis(dicarbollide) G where two close K+…O 





Figure 6. Comparison of the K+ environments in the optimized geometry of K[6]- and the X-ray geometry 
of G. The second cobaltabis(dicarbollide)-diethylene glycol arm attached to the para-carborane in K[6]- is 
omitted for clarity. 
 
Antimicrobial studies 
The antimicrobial properties of the four new high boron content compounds 
Na[3], K2[4], Na[5] and K2[6] were tested along with the commercially available salt 
Cs[1] using microdilution tests to determine the Minimum Inhibitory Concentration 
(MIC) and Minimum Bactericidal Concentration (MBC) against clinical isolates; 
including 5 Gram-negative bacteria (3 Escherichia coli and 2 Pseudomonas aeruginosa 
strains), 4 Gram-positive bacteria (2 Enterococcus faecalis and 2 Staphylococcus aureus 
strains), and 3 yeast Candida albicans strains. These results, presented in Table 2, 
revealed that the five compounds mainly have good antibacterial activity against Gram-
positive bacteria (MICs ranging from 1 to 16 mg/L), and moderate antifungal activity for 
Candida albicans (MICs ranging from 4 to 32 mg/L). None of the salts showed 
antibacterial effects against the clinical isolates of Gram-negative bacteria E. coli and P. 
aeruginosa (MICs ranged from 256 to >512 mg/L). MBC values indicated that these 
compounds have a bactericidal effect rather than bacteriostatic in most cases for Gram-
16 
 
positive bacteria, since the ratio MBC/MIC was ≤ 4, except for Na[3] against E. faecalis 
190093 (MBC/MIC=32). In the case of Candida albicans, the MBC values of Na[5] 
compound against two of the isolates (C. albicans 180228 and C. albicans 181721) were 
higher than the MIC×2 what suggest this compound could have a fungistatic effect rather 
than fungicidal, whereas a fungicidal effect was confirmed for Na[3], K2[4], K2[6] and 
Cs[1]. Of note, no difference in MIC or MBC was found between the wild type S. aureus 
and the MRSA strains, which suggests that the mechanisms of the MRSA strain do not 
confer resistance to the present compounds. 
 
Table 2. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal 
Concentration (MBC) (indicated as mg/L) of cobaltabis(dicarbollides) on clinical isolates 
cause of infection. § Multidrug-resistant strains. 
 
Na[3] K2[4] Na[5] K2[6] Cs[1] 
Strain MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC 
Gram-negative bacteria                     
E. coli  LF82 § >512 >512 >512 >512 >512 >512 >512 >512 256 512 
E. coli WT 190940 >512 >512 >512 >512 >512 >512 >512 >512 256 256 
E. coli BLEE 192348 § >512 >512 >512 >512 >512 >512 >512 >512 256 256 
P. aeruginosa WT 190089 >512 >512 512 >512 >512 >512 512 >512 256 256 
P. aeruginosa IMI-R 187182 §  >512 >512 512 >512 >512 >512 512 >512 256 256 
Gram-positive bacteria                     
E. faecalis WT 190093 1 32 2 4 4 8 2 4 16 32 
E. faecalis WT 194844 1 4 2 4 4 8 4 8 16 16 
S. aureus WT 180895 1 4 8 16 16 32 4 16 16 32 
S. aureus MRSA 182851 § 1 2 8 16 16 32 ≤4* ≤16* 16 32 
Yeast     
  
    
  
    
C. albicans 180228 16 16 4 4 32 >128 4 8 32 64 
C. albicans 181721 16 32 4 ≤16* 32 >128 4 8 32 64 
C. albicans 191026 16 16 4 4 32 32 4 8 32 64 
17 
 
*Consistent results could not be obtained. The value indicates the maximum MIC or MBC from four assays.  
Since the antimicrobial properties for H[1]23 and Na[1]26 have been reported 
elsewhere, comparison between the reported MIC data for Na[1] and our MIC data for 
Cs[1] reveals similarities and differences. The microbial strains tested are not identical 
but salts of [1]- clearly have antibacterial effects on Gram-positive bacteria and no 
antibacterial effects on Gram-negative bacteria. It seems that Na[1] is more effective than 
Cs[1] for Gram-positive bacteria with MIC80 of ca 2.7 mg/L for Na[1] and MIC of ca 16 
mg/L for Cs[1] respectively. An antimicrobial study on different [1]- salts with identical 
microbial strains is desirable to confirm that different cations influence the antimicrobial 
properties of these salts. In concordance with our results, the reported anionic and 
zwitterion cobaltabis(dicarbollide) derivatives, C-F (Chart 2), selectively inhibited the 
growth of Gram-positive but not Gram-negative bacteria meaning a relatively narrow 
antimicrobial spectrum.24-26 Other anionic cobaltabis(dicarbollide) derivatives, A and B 
(Chart 2), have wide antimicrobial ranges as they were also effective against Gram-
negative bacteria.23 
The cobaltabis(dicarbollide) derivatives, Na[3], K2[4], Na[5] and K2[6], examined 
showed a remarkable higher antibacterial effect on Gram-positive bacteria. For example, 
the MIC values for compounds A-C are 10, 13 and 8 mg/L respectively for the MRSA 
strain23,24 whereas the salt Na[3] showed the highest inhibitory effect to S. aureus with a 
MIC of 1 mg/L and an MBC of 2 mg/L towards MRSA strain 182851. This strain is 
resistant to penicillin, amoxicillin/clavulanic acid, oxacillin, tobramycin, amikacin, 
ciprofloxacin, levofloxacin and erythromycin (Table S1). The cobaltabis(dicarbollide) 
derivative C was reported to kill S. aureus MRSA by inducing an increase in the reactive 
oxygen species production,24 what in turn induced irreversible damage to the cell 
wall/membrane. The antifungal activities against the studied C. albicans strains were 
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similar to compounds A and B described by some of us earlier.23 The larger assemblies 
[K]2[4] and K2[6] displayed the highest fungal potencies with MICs of 4 mg/L. 
 All the new anionic [3]--[6]2- derivatives possess a hydrophilic-lipophilic balance: 
hydrophilic from the anionic ethylene glycol cobaltallabis(dicarbollide) clusters and 
lipophilic from the aryl or p-carboranyl groups. From a consideration of the structure-
activity relationships, it seems reasonable to conclude that the introduction of two 
hydrophilic ethylene glycol cobaltabis(dicarbollide) anions bonded to the lipophilic 
phenyl or p-carboranyl groups leads to the increased antifungal activity. The 3D p-
carborane unit, which is more lipophilic than the aromatic unit, provide the highest 
antifungal activity to [6]2-. Moreover, the higher electron-withdrawing character of the 
closo carborane at the carbon atom compared to the aromatic ring may be the difference 
in biological activity between [6]2- and [4]2-. 
 The fact that these compounds are selective for Gram-positive bacteria and fungi 
not only questions the mechanism of action but also suggests that the outer membrane 
and/or the expression of efflux pumps of Gram-negative bacteria may protect from the 
action of these molecules. Future studies are needed to demonstrate the mechanism of 
action of these compounds. Moreover, regarding their antimicrobial potential, new 
cobaltabis(dicarbollide) variants like A and B with increased effectiveness against Gram-
negative bacteria are of great interest since Gram-negative multi-resistant bacteria are on 
the top of the global priority list for research and development of new drugs (WHO). 
 
Conclusions 
New hybrid assemblies containing cobaltabis(dicarbollide) anions and aromatic 
or carborane units with enhanced water solubility were synthesized to explore their 
potential as suitable antimicrobial agents. The electronic, hydrophobic, and steric 
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differences between 2D aromatic ring and 3D aromatic carborane cluster provide 
different hydrophilic-lipophilic balances in the new compounds and result in differences 
in their antibacterial and antifungal activities. These cobaltabis(dicarbollide) assemblies 
tested here are potential narrow-spectrum antimicrobial agents, with very good 
bactericidal effect (MIC 1-8 mg/L) against Gram-positive bacteria and antifungal effect 
(MIC 4 mg/L) in the case of the larger assemblies (K2[4] and K2[6]) against C. albicans. 
In particular, one compound (Na[3]) is very promising as an antimicrobial agent because 
low doses (MIC 1 mg/L) destroy the methicillin-resistant S. aureus (MRSA) strain we 
have evaluated, and this organism is classified as a high priority pathogen for R&D of 
new antibiotics by the World Health Organization. The ineffectiveness of these 
assemblies against Gram-negative bacteria suggests that decreased intracellular 
accumulation may hamper the antibacterial action of these compounds, making Gram-
negative bacteria naturally protected. Studying the mechanism of action in these 
compounds may shed light on the design of new cobaltabis(dicarbollide) assemblies with 




Materials and instrumentation  
All reagents in the present work were obtained from Sigma-Aldrich and used 
without further purification. Reagent grade organic solvents were obtained from Carlo 
Erba and high purity de-ionized water was obtained by passing distilled water through a 
nano-pure Milli-Q water purification system. 
All manipulations were carried out under nitrogen atmosphere. Dry DME was 






11,12  and [N(CH3)4][3,3’-
Co(8-O(CH2CH2O)2C(O)C6H5-1,2-C2B9H10)(1’,2’-C2B9H11)]
30 were prepared according 
to the literature. 
 IR spectra (ʋ, cm-1) were obtained using the Shimadzu FTIR-8300 
spectrophotometer. UV-Vis spectroscopy was performed on a Cary 50 Scan (Varian) UV-
Vis spectrophotometer with 1 cm quartz cells. The 1H and 1H{11B}-NMR (300.13/400.13 
MHz), 13C{1H}-NMR (75.47 MHz) and 11B and 11B{1H}-NMR (96.29 /128.37 MHz) 
spectra were recorded on a Bruker ARX 300 or a DPX 400 instrument equipped with the 
appropriate decoupling accessories. All NMR spectra were performed in the indicated 
deuterated solvent at 22ºC. 11B and 11B{1H}-NMR chemical shifts were referenced to 
external BF3·OEt2 at 0.0 ppm while the 
1H, 1H{11B}, and 13C{1H}-NMR shifts were 
referenced to SiMe4 at 0.0 ppm. Elemental analyses were performed using a CHNS-O 
Elemental Analyzer EA-1108 from Fisons. ESI-MS experiments were recorded on a 
Navigator LC/MS chromatography from Thermo Quest Finnigan, using acetonitrile as a 
mobile phase. Thermogravimetric analysis (TGA) was performed using a Netzsch STA 
449 thermal analyzer at a heating rate of 10 °C min-1 under an Ar atmosphere. 
 
Synthesis of Na[1-COO-1,12-C2B10H11]. 
This ligand was prepared by neutralization of the 1-COOH-1,12-C2B10H11 acid. Dried 
sodium carbonate (17 mg, 0.16 mmol) and 1-COOH-1,12-C2B10H11 (60 mg, 0.319 mmol) 
were dissolved in 15 mL of distilled water at room temperature. After stirring 2 hours, 
the solvent was removed. The resulting solid was filtered off and dried in vacuum. Yield: 
65 mg (97 %) of pure Na[1-COO-1,12-C2B10H11] was obtained. IR ν(cm
-1): 3306 (O-Na), 
3053 (Cc-H), 2888 (C-H)alkyl, 2600 (B-H), 1626 (C=O), 1347 δ(CH). 
1H NMR (400 MHz, 
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(CD3)2CO): δ 3.35 (s, 1H, C-H), 3.10-1.4 (m, 10H, B-H). 
1H{11B} NMR (400 MHz, 
(CD3)2CO): δ 3.35 (s, 1H, C-H), 2.40 (s, 5H, B-H), 2.13 (s, 5H, B-H). 
11B NMR (96.3 
MHz, (CD3)2CO): δ -10.0 (d, 
1J(B,H) = 176 Hz, 5B), -12.5 (d, 1J(B,H) = 176 Hz, 5B). 
  
Synthesis of Na[3,3’-Co(8-O(CH2CH2O)2C(O)C6H5-1,2-C2B10H10)(1’,2’-C2B9H11)], 
Na[3]. 
A yellowish ion exchange resin was kept in HCl solution (3 M) for 24 h then filled into a 
column. A solution of HCl (3M) was passed through this column until a transparent 
solution appeared from the column. Excess HCl was removed by washing the resin using 
distilled water till the exit solution had neutral pH. A solution of NaCl (3M) was then 
passed slowly through the column to change H+ ions into Na+ ions on the column. 
Distilled water was used to remove excess NaCl. An acetonitrile/water (50/50) mixture 
was passed through the column and a minimum amount of the same solution was used to 
dissolve a sample of complex [N(CH3)4][3]. The orange solution was passed through the 
column several times then the solvent was evaporated from the orange solution in vacuo 
to give 90% yield of the Na[3] compound. FTIR-ATR: ѵ= 3038 (Cc-H), 2918, 2865 (C-
H)alkyl, 2528 (B-H), 1699 (C=O), 1440 δ(CH2), 1279 δ(CH), 1131 (C-O-C). 
1H NMR 
((CD3)2CO): δ= 8.06 (m, 2H, C6H5), 7.64 (t, 1H, C6H5), 7.53 (t, 2H, C6H5), 4.30 (t, 2H, 
OCH2CH2), 4.30 (br s, 4H, Cc-H), 3.84 (t, 2H, OCH2CH2), 3.69 (m, 4H, OCH2CH2). 
1H{11B} NMR ((CD3)2CO): δ= 8.06 (m, 2H, C6H5), 7.64 (t, 1H, C6H5), 7.53 (t, 2H, C6H5), 
4.30 (t, 2H, OCH2CH2), 4.30 (br s, 4H, Cc-H), 3.84 (t, 2H, OCH2CH2), 3.69 (m, 4H, 
OCH2CH2), 2.79, 2.71, 2.45, 2.01, 1.80, 1.67, 1.58, 1.47 (B-H). 
13C{1H} NMR 
((CD3)2CO): δ= 165.87 (s, COO), 132.88 (s, C6H5), 129.40 (s, C6H5), 128.46 (s, C6H5), 
71.03 (s, OCH2), 68.81 (s, OCH2), 68.50 (s, OCH2), 64.31 (s, OCH2), 54.36 (s, Cc-H). 
11B 
NMR ((CD3)2CO): δ= 23.0 (s, 1B, B(8)), 4.0 (d, 
1J(B,H) = 151 Hz, 1B), 0.6 (d, 1J(B,H) 
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= 141 Hz, 1B), -2.4 (d, 1J(B,H) = 154 Hz,  1B), -3.4 (d, 1J(B,H) = 146 Hz, 2B), -7.5 (d, 
1J(B,H) = 102 Hz), -8.3 (d, 1J(B,H) = 94 Hz, 4B), -17.1 (d, 1J(B,H) = 156 Hz, 2B), -20.3 
(d, 1J(B,H) = 156 Hz, 2B, ), -21.8 (d, 1J(B,H) = 147 Hz, 1B), -28.2 (d, 1J(B,H) = 170 Hz, 





Under an inert atmosphere, a mixture of dried terephthalic acid (10.1 mg, 0.061 mmol) 
and potassium carbonate (67.4 mg, 0.487 mmol) were refluxed in 10 mL of DME for 2 
h. Then, a solution of 2 (50 mg, 0.122 mmol) in 5 mL of DME was added dropwise to the 
solution. After refluxing overnight, the excess of potassium carbonate was filtered off and 
discarded. The solvent was removed and washed with petroleum ether. The obtained 
compound was dissolved in water and acetonitrile, then filtrated. The solvent was 
removed. The obtained orange powder was passed twice through a column 
chromatography on silica (CH2Cl2/MeOH 9:1) to give a yellow-orange fraction. The 
obtained solid was washed twice with 10 mL of diethyl ether and dried in vacuum to give 
34.8 mg (53.7 %) of K2[4]. Elemental analysis for C24H62B36Co2O8K2: Calc.: C, 27.09; 
H, 5.84. Found: C, 26.96; H, 5.65. FTIR-ATR: ѵ= 3021 (Cc-H), 2969, 2900 (C-H)alkyl, 
2533 (B-H), 1713 (C=O), 1446, 1407 δ(CH2), 1254 δ(CH), 1078, 1020 (C-O-C). 
1H NMR 
((CD3)2CO): δ= 8.16 (s, 4H, C6H4), 4.47 (t, 4H, OCH2CH2), 4.26 (br s, 8H, Cc-H), 3.85 
(t, 4H, OCH2CH2), 3.60 (m, 8H, OCH2CH2). 
13C{1H} NMR ((CD3)2CO): δ 166.09 (s, 
COO), 134.96 (s, C6H4), 130.37 (s, C6H4), 72.71 (s, OCH2), 71.76 (s, OCH2), 69.51 (s, 
OCH2), 65.50 (s, OCH2), 55.19 (s, Cc-H), 47.22 (s, Cc-H). 
11B NMR ((CD3)2CO): δ 23.0 
(s, 2B, B(8)), 4.0 (s, 2B), 0.4 (s, 2B), -2.5 (s, 2B), -4.4 (s, 4B), -7.4 (s, 4B), -8.3 (s, 8B), -




-, 60%); 428,2 [3,3’-Co (8-(CH2CH2O)2OH-
1,2-C2B9H10)(1,2-C2B9H11)]
-, 60%); 493.2 (M/2, 100%); 506.7 ((M+C2H3)/2, 45%), 
where M is the molecular weight of the dianion, [1’’,4’’-{3,3’-Co(8-O(CH2CH2O)2CO-
1,2-C2B9H10)(1’,2’-C2B9H11)}2-C6H4]
2-, [4]2-, and 620.2 ([3,3’-Co(8-HOCH2CH2-OOC-
C6H4-COO-(CH2CH2O)2-1,2-C2B9H10)(1,2-C2B9H11)]




Under an inert atmosphere, dried Na[1-COO-1,12-C2B10H11] (26 mg, 0.122 mmol) and 2 
(50 mg, 0.122 mmol) were refluxed in 10 mL of anhydrous DME. After stirring over-
weekend, the solvent was removed. This was filtered off, washed with petroleum ether 
and dried in vacuum; 49.3 mg (60%) of Na[5] was obtained. Elemental Analysis for 
C11H40B28CoO4Na: Calc: C, 21.27; H, 6.49. Found: C, 21.13; H, 6.22. FTIR-ATR: ν= 
3400,1706 (H2O), 3048 (Cc-H), 2914, 2871, 2826 (C-H)alkyl, 2534 (B-H), 1714 (C=O), 
1456 δ(CH2), 1188, 1121 (C-O-C). 
1H NMR ((CD3)2CO): δ= 4.27 (br s, 4H, Cc-H), 4.16 
(t, 2H, OCH2CH2), 3.66 (t, 2H, OCH2CH2), 3.58 (t,
 2H, OCH2CH2), 3.52 (t,
 2H, 
OCH2CH2), 3.32 (s, 1H, para-carborane Cc-H). 
1H{11B} NMR ((CD3)2CO): δ= 4.28 (br 
s, 4H, Cc-H), 4.17 (t, 2H, OCH2CH2), 4.00 (s, 1H, Cc-H), 3.65 (t, 2H, OCH2CH2), 3.58 (t,
 
2H, OCH2CH2), 3.52 (t,
 2H, OCH2CH2), 3.32 (s, 1H, para-carborane Cc-H), 2.93 (s, 4H, 
B-H), 2.78 (s, 2H, B-H),  2.71 (s, 1H, B-H),  2.43 (s, 6H, B-H + para-carborane B-H), 
2.22 (s, 5H, para-carborane B-H), 2.01 (s, 2H, B-H), 1.80 (s, 2H, B-H), 1.67 (s, 2H, B-
H), 1.58 (s, 2H, B-H), 1.47 (s, 1H, B-H). 13C{1H} NMR ((CD3)2CO): δ= 162.36 (s, COO), 
72.78 (s, C-COO), 70.65 (s, OCH2), 69.41 (s, OCH2), 69.05 (s, OCH2), 67.63 (s, OCH2), 
55.31 (s, Cc-H), 47.30 (s, Cc-H), 41.32 (s, C-H). 
11B NMR ((CD3)2CO): δ= 23.0 (s, 1B, 
B(8)), 3.9 (d, 1J(B,H) = 136 Hz, 1B), 0.4 (d, 1J(B,H) = 142 Hz, 1B), -2.6 (d, 1J(B,H)= 157 
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Hz, 1B), -4.3 (d, 1J(B,H) = 162 Hz, 4B), -7.3 (d, 1J(B,H) = 97 Hz, 2B), -8.6 (d, 1J(B,H) = 
100Hz, 4B), -13.5 (d, 1J(B,H) = 171 Hz, 5B), -15.3 (d, 1J(B,H) = 175 Hz, 5B), -19.0 (d, 
1J(B,H) = 152 Hz, 2B), -20.6 (d, 1J(B,H)= 157 Hz, 2B), -22.1 (d, 1J(B,H) = 140 Hz, 2B), 
-28.7 (d, 1J(B,H) = 154 Hz, 2B). ESI-MS (m/z): 598.4 (M, 100%) where M is the 






Under an inert atmosphere, a mixture of dried 1,12-(COOH)2-C2B10H10 (23 mg, 0.1 
mmol) and potassium carbonate (107 mg, 0.775 mmol) were refluxed in 10 mL of 
anhydrous acetone for 2 hours. Then, a solution of 2 (80 mg, 0.195 mmol) in 5 mL of 
anhydrous acetone was added dropwise in the solution. After stirring overnight, the 
excess of potassium carbonate was filtered off and discarded. The solvent was removed, 
washed with petroleum ether and dried in vacuum. Yield: 103 mg (94%) was obtained. 
Elemental Analysis for C20H68B46Co2O8K2: Calc: C, 21.26; H, 6.06. Found: C, 21.11; H, 
6.27. FTIR-ATR: ѵ= 3039 (Cc-H), 2961, 2921, 2881 (C-H)alkyl, 2532 (B-H), 1702 (C=O), 
1440, 1411 δ(CH2), 1257 δ(CH), 1105, 1020 (C-O-C). 
1H NMR ((CD3)2CO): δ= 4.25 (br 
s, 8H, Cc-H), 4.16 (m, 4H, OCH2CH2), 3.63 (m, 4H, OCH2CH2), 3.57 (m, 4H, OCH2CH2), 
3.50 (m, 4H, OCH2CH2). 
1H{11B} NMR ((CD3)2CO): δ= 4.25 (br s, 8H, Cc-H), 4.16 (m, 
4H, OCH2CH2), 3.63 (m, 4H, OCH2CH2), 3.57 (m, 4H, OCH2CH2), 3.50 (m, 4H, 
OCH2CH2), 2.92 (s, 8H, B-H),  2.75 (s, 6H, B-H), 2.49 (s, 4H, B-H + para-carborane B-
H), 2.44 (s, 4H, para-carborane B-H), 2.40 (s, 4H, para-carborane B-H), 2.01 (s, 4H, B-
H), 1.81 (s, 4H, B-H), 1.67 (s, 4H, B-H), 1.58 (s, 4H, B-H), 1.49 (s, 2H, B-H). 13C{1H} 
NMR ((CD3)2CO): δ= 163.81 (s, COO), 72.86 (s, C-COO), 69.48 (s, OCH2), 69.10 (s, 
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OCH2), 67.81 (s, OCH2), 67.65 (s, OCH2), 55.25 (s, Cc-H), 47.35 (s, Cc-H). 
11B NMR 
((CD3)2CO): δ= 24.2 (s, 2B, B(8)), 5.2 (d, 
1J(B,H)= 135Hz, 2B), 1.6 (d, 1J(B,H)= 143 Hz, 
2B), -1.4 (d, 1J(B,H)= 153 Hz, 2B), -3.0 (d, 1J(B,H)= 167 Hz, 2B), -6.0 (d, 1J(B,H)= 104 
Hz, 4B), -7.2 (d, 1J(B,H)= 114 Hz, 6B), -12.8 (d, 1J(B,H) = 169 Hz, 10B),  -16.1 (d, 
1J(B,H) = 159 Hz, 4B),  -19.2 (d, 1J(B,H) = 153 Hz, 4B), -20.9 (d, 1J(B,H) = 163 Hz, 2B), 
-27.3 (d, 1J(B,H) = 140 Hz, 2B). ESI-MS (m/z): 525.8 (M/2, 100%), 642.3 (3,3’-Co(8-
(HOOC-C2B10H10-COO-(CH2CH2O)2-1,2-C2B9H10)(1,2-C2B9H11)]
-, 73%), 1091.7 (M + 




Microorganisms and growth media. 
Clinical bacterial (N=8) and yeast (N=3) isolates responsible for human infections were 
used to test the antimicrobial properties of the compounds. These microorganisms were 
isolated at the Hospital Reina Sofía of Córdoba (Spain) in 2018 and 2019. In particular, 
as Gram-negative bacteria, two strains of Escherichia coli and two Pseudomonas 
aeruginosa were tested, including strains susceptible to commonly used antimicrobials 
(E. coli 190940 and P. aeruginosa 190089) or multi-drug resistant (E. coli BLEE 192348 
and P. aeruginosa IMI 187182). E. coli strain LF82, previously isolated from a patient 
with ileal Crohn’s disease was also included.31 As Gram-positive bacteria, we tested two 
Enterococcus faecalis (E. faecalis 190093 and E. faecalis 194844), and two 
Staphylococcus aureus (S. aureus MRSA 182851, which is multidrug-resistant, and S. 
aureus 180895). Yeast strains belonged to the species Candida albicans (C. albicans 
180228, C. albicans 181721 and C. albicans 191026). Bacterial strains were 
phenotypically characterized by the Microscan Walkaway-96 System; the antimicrobial 
resistance profiles are presented in Table S1. 
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Luria-Bertani (LB) broth was used for growing the E. coli species, brain heart infusion 




Minimum inhibitory concentration (MIC) was determined by broth microdilution 
following standardized guidelines (International Standards Organisation, 2006), and the 
minimum bactericidal concentration (MBC) by counting viable cells at MIC and MIC×2 
concentrations following the CLSI standard protocols (CLSI, 1999). 
Bacterial suspensions 
Overnight bacterial cultures were prepared in 1.5 mL of LB (E. coli) or BHI (P. 
aeruginosa, E. faecalis and S. aureus) in glass tubes with cotton plugs and incubating 
them for 16-18 h at 37 ºC without shaking. Bacterial density was measured at an optical 
density of 620 nm and bacterial suspensions were prepared at a final concentration of 
1×106 CFU / mL in cation-adjusted Mueller Hinton (MH) broth.  
Yeast suspensions 
Candida inoculums were prepared by resuspending 5 individual colonies in at least 3 ml 
of sterile water. Optical density was measured 530 nm and suspensions were prepared in 
sterile water at a final concentration of 1 – 5×105 CFU / mL. 
Compounds stock solutions 
The stock solutions were prepared at 1024 mg/l with sterile Milli Q water and kept at -
20ºC or at 4ºC a maximum of 1 month. Na[5] and K2[6] were first diluted with dimethyl 
sulfoxide (DMSO) in a concentration of 50 mg/ml and then sterile water was added until 
the final concentration was of 1024 mg/L. All the other compounds were diluted directly 
with water at 1024 mg/L.  
27 
 
MIC and MBC determinations 
For bacterial tests, serial dilutions of the compounds were prepared in cation-adjusted 
Mueller Hinton broth in a polystyrene 96-well plate. Concentrations tested were 512, 256, 
128, 64, 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.125 and 0 mg/L. Bacteria were inoculated at a final 
concentration of 5×105 CFU/mL in final volume of 100 µL. Microplates were incubated 
for 18 h at 37 °C in aerobic conditions. 
The medium used to test Candida was RPMI with 2% glucose and L-glutamine, and the 
concentrations of the compounds tested were 128, 64, 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.125 
and 0 mg/L. The test was done in a final volume of 200 µL with 1-5 ×105 CFU/mL per 
well. Microplates were incubated for 24 h at 37 °C in aerobic conditions. All tests were 
done in triplicate.  
The MIC was determined as the lowest concentration of the compound (mg/L) needed to 
inhibit the growth of the microorganism, which was observed by the absence of visible 
growth in the well. The MBC was determined by plating 20 µL of the suspension 
corresponding to the MIC and the subsequent one (MIC×2) into LB agar plates that did 
not contain the compound. The MBC was determined as the lowest concentration of 




Spectra (IR, 1H, 1H{11B}, 13C{1H}, 11B, 11B{1H}, ESI-MS, TGA/DSC) and antibiotic 
resistant profiles (MIC; mg/L) against several Gram-positive bacteria. Cartesian 
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